Marking. 15.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx LICENSED PRODUCT(S) (or their containers or labels) made, SOLD, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 14 contracts
Samples: Exclusive License Agreement With Equity, Exclusive License Agreement With Equity, Exclusive License Agreement
Marking. 15.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx mark LICENSED PRODUCT(S) (or their containers or labels) made, SOLD, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 11 contracts
Samples: Exclusive License Agreement, Exclusive License Agreement With Equity, Exclusive License Agreement With Equity
Marking. 15.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx mark, and have SUBLICENSEE’S mark, LICENSED PRODUCT(S) (or their containers or labels) made, SOLD, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 7 contracts
Samples: Exclusive License Agreement, Exclusive License Agreement, Exclusive License Agreement
Marking. 15.1 14.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx mark LICENSED PRODUCT(S) (or their containers or labels) made, SOLD, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 5 contracts
Samples: Non Exclusive License Agreement, Non Exclusive License Agreement, Non Exclusive License Agreement
Marking. 15.1 Prior to the issuance of patents under REGENTS' ’ PATENT RIGHTS, LICENSEE agrees to xxxx LICENSED PRODUCT(S) (or their containers or labels) made, SOLDsold, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT Agreement with the words "“Patent Pending," ” and following the issuance in the United States of one or more patents under REGENTS' ’ PATENT RIGHTS, with the numbers of the REGENTS' ’ PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD sold in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 3 contracts
Samples: Exclusive License Agreement (Berkeley Lights, Inc.), Exclusive License and Bailment Agreement (Adverum Biotechnologies, Inc.), Ambrx Biopharma Inc.
Marking. 15.1 14.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx LICENSED PRODUCT(S) (or their containers or labels) made, SOLDsold, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT Agreement with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of the REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD sold in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 3 contracts
Samples: Non Exclusive License Agreement, Non Exclusive License1, Nonexclusive License*
Marking. 15.1 14.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx LICENSED PRODUCT(S) (or their containers or labels) made, SOLD, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 2 contracts
Samples: Non Exclusive License Agreement, Non Exclusive License Agreement
Marking. 15.1 Prior to the issuance in the United States of patents under REGENTS' ’ PATENT RIGHTS, LICENSEE agrees to xxxx LICENSED PRODUCT(S) (or their containers or labels) made, SOLD, licensed or otherwise disposed of SOLD by it in the United States under the license granted in this AGREEMENT Agreement with the words "“Patent Pending," ” and following the issuance in the United States of one or more patents under REGENTS' ’ PATENT RIGHTS, with the patent numbers of the REGENTS' ’ PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 2 contracts
Samples: Exclusive License and Bailment Agreement (4D Molecular Therapeutics Inc.), Exclusive License and Bailment Agreement (4D Molecular Therapeutics Inc.)
Marking. 15.1 14.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx mark LICENSED PRODUCT(S) (or their containers or labels) made, SOLDsold, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT Agreement with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of the REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD sold in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 1 contract
Samples: Non Exclusive License1
Marking. 15.1 Prior to the issuance of patents under REGENTS' PATENT RIGHTS, LICENSEE agrees to xxxx mark LICENSED PRODUCT(S) (or their containers or labels) made, had made, SOLD, licensed or otherwise disposed of by it in the United States under the license granted in this AGREEMENT with the words "Patent Pending," and following the issuance in the United States of one or more patents under REGENTS' PATENT RIGHTS, with the numbers of REGENTS' PATENT RIGHTS. All LICENSED PRODUCTS shipped to, manufactured, or SOLD in other countries will be marked in such manner as to conform with the patent laws and practice of such countries.
Appears in 1 contract
Samples: Exclusive License Agreement (Kiora Pharmaceuticals Inc)